What's in Cloudbreak Therapeutics, LLC's pipeline?

Cloudbreak Therapeutics, LLC has 7 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 5 in Phase 2, 1 in Phase 1.

Which companies overlap with Cloudbreak Therapeutics, LLC's portfolio?

Top competitors by shared drug class: Akeso, AltruBio Inc., Bristol-Myers Squibb, City of Hope Medical Center, Sinocelltech Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/cloudbreak-therapeutics-llc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-15 · How we verify

Cloudbreak Therapeutics, LLC — Portfolio Competitive Intelligence Brief

Cloudbreak Therapeutics, LLC pipeline: 0 marketed, 0 filed, 1 Phase 3, 5 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 5 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
CBT-001	CBT-001	phase 3

Therapeutic area mix

Oncology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Akeso · 1 shared drug class
AltruBio Inc. · 1 shared drug class
Bristol-Myers Squibb · 1 shared drug class
City of Hope Medical Center · 1 shared drug class
Sinocelltech Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Cloudbreak Therapeutics, LLC:

Cite this brief

Drug Landscape (2026). Cloudbreak Therapeutics, LLC — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/cloudbreak-therapeutics-llc. Accessed 2026-05-15.